David Mason Adler

David Adler practices at Alfond Center for Health in Augusta, Maine.

David Adler's NPI, 1851823314, was assigned on April 3, 2017. David Adler holds Maine license MD27150.

David Adler's primary practice is Alfond Center for Health, at 35 Medical Center Pkwy, Augusta, ME 04330 in Kennebec County. The practice phone is (207) 873-9841.

David Adler's primary practice is Alfond Center for Health in Augusta, Maine. David Adler is also affiliated with MaineGeneral Medical Center. The medical group on file is MaineGeneral Health. Dmand AI also links David Adler to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Adler practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is David Adler's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. David Adler is licensed in Maine.

CMS data shows 613 Medicare services from David Adler across 5 procedure codes in 2024, for 152 Medicare patients. Medicare paid $34,889 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 152 Medicare patients who saw David Adler in 2024. The largest group is 65 to 74, with 59 patients. 70% of them have high blood pressure, and 64% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Adler's median patient age at 73, with 49% women.

In 2024, David Adler wrote 582 Medicare Part D claims for 119 patients. 77% of them were for generic drugs. CMS names the drug for 329 of them, across 14 drugs with 11 or more claims each, at $955,110 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for David Adler for performance year 2024, reported as part of a group. David Adler accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to David Adler, published from 2011 to 2021. 2011 was the busiest year, with 9. The most frequent topics are Prostatic Neoplasms, Gene Expression Regulation, Neoplastic and Cell Line, Tumor. David Adler has published most often in Int J Mol Med. David Adler's most frequent co-authors are Mehmet Asim Bilen, MD, Mario Chih-Hsiung Karl Deng, MD and Albert Jang, MD.

CMS Open Payments shows 38 general payments to David Adler from 19 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 66% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,004.